Check-Cap (MBAI) Net Cash Flow Growth (3y) (2017 - 2024)
Check-Cap (MBAI) Net Cash Flow Growth (3y) (2017 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 58.74% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -43.12% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | -29.30% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 41.14% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 27.97% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 29.81% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -40.43% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -38.01% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 89.23% |
| 10 | Check-Cap | 8.23 Mn | 6.60 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -26.14% |
| Dec 31, 2023 | -161.77% |
| Sep 30, 2023 | 81.45% |
| Jun 30, 2023 | 46.69% |
| Mar 31, 2023 | 141.98% |
| Dec 31, 2022 | -123.71% |
| Sep 30, 2022 | 46.12% |
| Jun 30, 2022 | -333.56% |
| Mar 31, 2022 | 285.20% |
| Dec 31, 2021 | 198.53% |
| Sep 30, 2021 | 264.20% |
| Jun 30, 2021 | 2.25% |
| Mar 31, 2021 | 100.30% |
| Dec 31, 2020 | 208.38% |
| Sep 30, 2020 | 2.64% |
| Jun 30, 2020 | 107.36% |
| Mar 31, 2020 | 24.86% |
| Dec 31, 2019 | 33.95% |
| Sep 30, 2019 | -33.97% |
| Jun 30, 2019 | 44.71% |